M&A Deal Summary

NuChem Sciences Acquires IniTium

On October 31, 2022, NuChem Sciences acquired life science company IniTium

Acquisition Highlights
  • This is NuChem Sciences’ 1st transaction in the Life Science sector.
  • This is NuChem Sciences’ 1st transaction in Canada.
  • This is NuChem Sciences’ 1st transaction in Quebec.

M&A Deal Summary
Date 2022-10-31
Target IniTium
Sector Life Science
Buyer(s) NuChem Sciences
Deal Type Add-on Acquisition

Target

IniTium

Laval, Quebec, Canada
IniTium is a contract research organization (CRO) providing crucial knowledge-based expertise in structural biology at the initial stages of drug discovery to the biotech and pharmaceutical industry worldwide. The company understands the needs of the sector for productivity, speed, reliability, and profitability, and value high-quality, fast and professional industry-grade research services for the best interest of the customer. IniTium was formed in 2014 and is based in Laval, Quebec.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

NuChem Sciences

Saint-Laurent, Quebec, Canada
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

NuChem Sciences offers a variety of services to support international biotech and pharmaceutical industries in their efforts to identify and optimize pre-clinical candidates in the area of small molecule drug discovery and early development. NuChem Sciences was formed in 2011 and is based in Saint-Laurent, Quebec.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal